PDB Short entry for 1JQD HEADER TRANSFERASE 06-AUG-01 1JQD TITLE CRYSTAL STRUCTURE ANALYSIS OF HUMAN HISTAMINE METHYLTRANSFERASE TITLE 2 (THR105 POLYMORPHIC VARIANT) COMPLEXED WITH ADOHCY AND HISTAMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HISTAMINE N-METHYLTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HNMT, HMT; COMPND 5 EC: 2.1.1.8; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HNMT; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: DH5A; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX-4T-3 KEYWDS CLASSIC METHYLTRANSFERASE FOLD, PROTEIN-SUBSTRATE-COFACTOR COMPLEX, KEYWDS 2 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.R.HORTON,K.SAWADA,M.NISHIBORI,X.ZHANG,X.CHENG REVDAT 5 03-APR-24 1JQD 1 REMARK REVDAT 4 07-FEB-24 1JQD 1 REMARK REVDAT 3 04-OCT-17 1JQD 1 REMARK REVDAT 2 24-FEB-09 1JQD 1 VERSN REVDAT 1 06-AUG-02 1JQD 0 JRNL AUTH J.R.HORTON,K.SAWADA,M.NISHIBORI,X.ZHANG,X.CHENG JRNL TITL TWO POLYMORPHIC FORMS OF HUMAN HISTAMINE METHYLTRANSFERASE: JRNL TITL 2 STRUCTURAL, THERMAL, AND KINETIC COMPARISONS. JRNL REF STRUCTURE V. 9 837 2001 JRNL REFN ISSN 0969-2126 JRNL PMID 11566133 JRNL DOI 10.1016/S0969-2126(01)00643-8 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH L.YAN,R.E.GALINSKY,J.A.BERNSTEIN,S.B.LIGGETT, REMARK 1 AUTH 2 R.M.WEINSHILBOUM REMARK 1 TITL HISTAMINE N-METHYLTRANSFERASE PHARMACOGENETICS: ASSOCIATION REMARK 1 TITL 2 OF A COMMON FUNCTIONAL POLYMORPHISM WITH ASTHMA REMARK 1 REF PHARMACOGENETICS V. 10 261 2000 REMARK 1 REFN ISSN 0960-314X REMARK 1 DOI 10.1097/00008571-200004000-00007 REMARK 1 REFERENCE 2 REMARK 1 AUTH R.M.WEINSHILBOUM,D.M.OTTERNESS,C.L.SZUMLANSKI REMARK 1 TITL METHYLATION PHARMACOGENETICS: CATECHOL O-METHYLTRANSFERASE, REMARK 1 TITL 2 THIOPURINE METHYLTRANSFERASE, AND HISTAMINE REMARK 1 TITL 3 N-METHYLTRANSFERASE REMARK 1 REF ANNU.REV.PHARMACOL.TOXICOL. V. 39 19 1999 REMARK 1 REFN ISSN 0362-1642 REMARK 1 DOI 10.1146/ANNUREV.PHARMTOX.39.1.19 REMARK 1 REFERENCE 3 REMARK 1 AUTH S.AKSOY,R.RAFTOGIANIS,R.M.WEINSHILBOUM REMARK 1 TITL HUMAN HISTAMINE N-METHYLTRANSFERASE GENE: STRUCTURAL REMARK 1 TITL 2 CHARACTERIZATION AND CHROMOSOMAL LOCATION REMARK 1 REF BIOCHEM.BIOPHYS.RES.COMMUN. V. 219 548 1996 REMARK 1 REFN ISSN 0006-291X REMARK 1 DOI 10.1006/BBRC.1996.0271 REMARK 2 REMARK 2 RESOLUTION. 2.28 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.28 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 18.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.6 REMARK 3 NUMBER OF REFLECTIONS : 25213 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.205 REMARK 3 FREE R VALUE : 0.257 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2786 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.28 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 89.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2340 REMARK 3 BIN FREE R VALUE : 0.2840 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 271 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.017 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4385 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 68 REMARK 3 SOLVENT ATOMS : 303 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.91000 REMARK 3 B22 (A**2) : 0.91000 REMARK 3 B33 (A**2) : -1.81000 REMARK 3 B12 (A**2) : 3.28000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM SIGMAA (A) : 0.18 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.26 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.880 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.570 ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 RESIDUES LISTED IN REMARK 470 HAD LITTLE OR NO SIDE CHAIN DENSITY. REMARK 3 MANY RESIDUES AT N-TERMINUS HAD NO OR LITTLE VISIBLE DENSITY FOR REMARK 3 PROTEIN BACKBONE. SOME DENSITIES WERE MODELLED AS WATER MOLECULES REMARK 3 EVEN THOUGH THE REFINED REMARK 3 WATER MOLECULES WERE GREATER THAN 3.5 ANGSTROMS AWAY FROM REMARK 3 MACROMOLECULE REMARK 3 ATOMS. THESE DENSITIES WERE INDEED VISIBLE AS DISCRETE "WATER REMARK 3 OXYGEN"-LIKE REMARK 3 DENSITIES BUT COULD REPRESENT MOITIES OTHER THAN WATER. REMARK 4 REMARK 4 1JQD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-AUG-01. REMARK 100 THE DEPOSITION ID IS D_1000014065. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-DEC-99 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.2000 REMARK 200 MONOCHROMATOR : SI(111) DOUBLE-CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28605 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.280 REMARK 200 RESOLUTION RANGE LOW (A) : 18.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 7.700 REMARK 200 R MERGE (I) : 0.07900 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 25.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.28 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.36 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.8 REMARK 200 DATA REDUNDANCY IN SHELL : 8.20 REMARK 200 R MERGE FOR SHELL (I) : 0.26600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 10.50 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PARTIALLY REFINED 3.3A SEMET HNMT/ADOMET/HISTAMINE REMARK 200 STRUCTURE SOLVED BY MAD PHASING (CRYSTAL GROWN AT PH 7.5). REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.87 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 6000, ISOPROPANOL, SODIUM CITRATE, REMARK 280 GLYCEROL, PH 5.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 6 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 -X,-Y,Z REMARK 290 5555 Y,-X+Y,Z REMARK 290 6555 X-Y,X,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 SER A 3 REMARK 465 SER A 4 REMARK 465 SER A 10 REMARK 465 ASP A 11 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 SER B 3 REMARK 465 SER B 4 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 8 CG CD1 CD2 REMARK 470 PHE A 9 CG CD1 CD2 CE1 CE2 CZ REMARK 470 HIS A 12 CG ND1 CD2 CE1 NE2 REMARK 470 ARG A 20 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 21 CB CG CD NE CZ NH1 NH2 REMARK 470 ASN A 107 CB CG OD1 ND2 REMARK 470 GLU A 109 CB CG CD OE1 OE2 REMARK 470 GLU A 129 CG CD OE1 OE2 REMARK 470 LYS A 131 CG CD CE NZ REMARK 470 GLU A 132 CG CD OE1 OE2 REMARK 470 LYS A 149 CG CD CE NZ REMARK 470 LYS A 181 CG CD CE NZ REMARK 470 GLN A 192 CG CD OE1 NE2 REMARK 470 ASP A 194 CG OD1 OD2 REMARK 470 LEU A 195 CG CD1 CD2 REMARK 470 LYS A 214 CG CD CE NZ REMARK 470 LEU A 220 CG CD1 CD2 REMARK 470 ASP A 228 CB CG OD1 OD2 REMARK 470 GLU A 246 CG CD OE1 OE2 REMARK 470 ALA A 254 CB REMARK 470 ASP A 257 CG OD1 OD2 REMARK 470 ALA A 260 CB REMARK 470 LYS A 264 CB CG CD CE NZ REMARK 470 GLU A 270 CG CD OE1 OE2 REMARK 470 LYS A 275 CB CG CD CE NZ REMARK 470 GLU A 276 CB CG CD OE1 OE2 REMARK 470 SER B 7 OG REMARK 470 SER B 10 CB OG REMARK 470 ASP B 11 CG OD1 OD2 REMARK 470 HIS B 12 CB CG ND1 CD2 CE1 NE2 REMARK 470 ARG B 20 CB CG CD NE CZ NH1 NH2 REMARK 470 ARG B 21 CB CG CD NE CZ NH1 NH2 REMARK 470 GLU B 93 CG CD OE1 OE2 REMARK 470 GLU B 100 CG CD OE1 OE2 REMARK 470 LYS B 104 CG CD CE NZ REMARK 470 ASN B 107 CB CG OD1 ND2 REMARK 470 GLU B 109 CB CG CD OE1 OE2 REMARK 470 LYS B 130 CG CD CE NZ REMARK 470 LYS B 131 CB CG CD CE NZ REMARK 470 GLU B 132 CB CG CD OE1 OE2 REMARK 470 LYS B 149 CG CD CE NZ REMARK 470 ASP B 193 CB CG OD1 OD2 REMARK 470 LEU B 195 CG CD1 CD2 REMARK 470 ASP B 232 CB CG OD1 OD2 REMARK 470 GLU B 235 CB CG CD OE1 OE2 REMARK 470 ASP B 242 CG OD1 OD2 REMARK 470 GLU B 246 CG CD OE1 OE2 REMARK 470 ASN B 251 CG OD1 ND2 REMARK 470 THR B 253 OG1 CG2 REMARK 470 LYS B 264 CG CD CE NZ REMARK 470 GLN B 267 CB CG CD OE1 NE2 REMARK 470 GLU B 270 CG CD OE1 OE2 REMARK 470 LYS B 275 CG CD CE NZ REMARK 470 GLU B 276 CB CG CD OE1 OE2 REMARK 470 LYS B 278 CG CD CE NZ REMARK 470 VAL B 279 CB CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 8 -4.26 -46.02 REMARK 500 SER A 106 -71.89 -89.82 REMARK 500 ASN A 107 56.49 -63.32 REMARK 500 PHE A 230 64.66 -104.40 REMARK 500 ILE A 231 120.88 -178.41 REMARK 500 GLU B 28 -71.56 -42.77 REMARK 500 ASN B 107 9.98 86.60 REMARK 500 LYS B 131 -88.12 -28.30 REMARK 500 GLU B 132 -166.46 -123.96 REMARK 500 ASP B 194 13.25 -68.69 REMARK 500 GLU B 235 -70.25 -53.34 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAH A 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAH B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HSM A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HSM B 601 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1JQE RELATED DB: PDB REMARK 900 1JQE CONTAINS THE ILE105 POLYMORPHIC VARIANT COMPLEXED WITH REMARK 900 QUINACRINE INSTEAD OF HISTAMINE DBREF 1JQD A 1 292 UNP P50135 HNMT_HUMAN 1 292 DBREF 1JQD B 1 292 UNP P50135 HNMT_HUMAN 1 292 SEQRES 1 A 292 MET ALA SER SER MET ARG SER LEU PHE SER ASP HIS GLY SEQRES 2 A 292 LYS TYR VAL GLU SER PHE ARG ARG PHE LEU ASN HIS SER SEQRES 3 A 292 THR GLU HIS GLN CYS MET GLN GLU PHE MET ASP LYS LYS SEQRES 4 A 292 LEU PRO GLY ILE ILE GLY ARG ILE GLY ASP THR LYS SER SEQRES 5 A 292 GLU ILE LYS ILE LEU SER ILE GLY GLY GLY ALA GLY GLU SEQRES 6 A 292 ILE ASP LEU GLN ILE LEU SER LYS VAL GLN ALA GLN TYR SEQRES 7 A 292 PRO GLY VAL CYS ILE ASN ASN GLU VAL VAL GLU PRO SER SEQRES 8 A 292 ALA GLU GLN ILE ALA LYS TYR LYS GLU LEU VAL ALA LYS SEQRES 9 A 292 THR SER ASN LEU GLU ASN VAL LYS PHE ALA TRP HIS LYS SEQRES 10 A 292 GLU THR SER SER GLU TYR GLN SER ARG MET LEU GLU LYS SEQRES 11 A 292 LYS GLU LEU GLN LYS TRP ASP PHE ILE HIS MET ILE GLN SEQRES 12 A 292 MET LEU TYR TYR VAL LYS ASP ILE PRO ALA THR LEU LYS SEQRES 13 A 292 PHE PHE HIS SER LEU LEU GLY THR ASN ALA LYS MET LEU SEQRES 14 A 292 ILE ILE VAL VAL SER GLY SER SER GLY TRP ASP LYS LEU SEQRES 15 A 292 TRP LYS LYS TYR GLY SER ARG PHE PRO GLN ASP ASP LEU SEQRES 16 A 292 CYS GLN TYR ILE THR SER ASP ASP LEU THR GLN MET LEU SEQRES 17 A 292 ASP ASN LEU GLY LEU LYS TYR GLU CYS TYR ASP LEU LEU SEQRES 18 A 292 SER THR MET ASP ILE SER ASP CYS PHE ILE ASP GLY ASN SEQRES 19 A 292 GLU ASN GLY ASP LEU LEU TRP ASP PHE LEU THR GLU THR SEQRES 20 A 292 CYS ASN PHE ASN ALA THR ALA PRO PRO ASP LEU ARG ALA SEQRES 21 A 292 GLU LEU GLY LYS ASP LEU GLN GLU PRO GLU PHE SER ALA SEQRES 22 A 292 LYS LYS GLU GLY LYS VAL LEU PHE ASN ASN THR LEU SER SEQRES 23 A 292 PHE ILE VAL ILE GLU ALA SEQRES 1 B 292 MET ALA SER SER MET ARG SER LEU PHE SER ASP HIS GLY SEQRES 2 B 292 LYS TYR VAL GLU SER PHE ARG ARG PHE LEU ASN HIS SER SEQRES 3 B 292 THR GLU HIS GLN CYS MET GLN GLU PHE MET ASP LYS LYS SEQRES 4 B 292 LEU PRO GLY ILE ILE GLY ARG ILE GLY ASP THR LYS SER SEQRES 5 B 292 GLU ILE LYS ILE LEU SER ILE GLY GLY GLY ALA GLY GLU SEQRES 6 B 292 ILE ASP LEU GLN ILE LEU SER LYS VAL GLN ALA GLN TYR SEQRES 7 B 292 PRO GLY VAL CYS ILE ASN ASN GLU VAL VAL GLU PRO SER SEQRES 8 B 292 ALA GLU GLN ILE ALA LYS TYR LYS GLU LEU VAL ALA LYS SEQRES 9 B 292 THR SER ASN LEU GLU ASN VAL LYS PHE ALA TRP HIS LYS SEQRES 10 B 292 GLU THR SER SER GLU TYR GLN SER ARG MET LEU GLU LYS SEQRES 11 B 292 LYS GLU LEU GLN LYS TRP ASP PHE ILE HIS MET ILE GLN SEQRES 12 B 292 MET LEU TYR TYR VAL LYS ASP ILE PRO ALA THR LEU LYS SEQRES 13 B 292 PHE PHE HIS SER LEU LEU GLY THR ASN ALA LYS MET LEU SEQRES 14 B 292 ILE ILE VAL VAL SER GLY SER SER GLY TRP ASP LYS LEU SEQRES 15 B 292 TRP LYS LYS TYR GLY SER ARG PHE PRO GLN ASP ASP LEU SEQRES 16 B 292 CYS GLN TYR ILE THR SER ASP ASP LEU THR GLN MET LEU SEQRES 17 B 292 ASP ASN LEU GLY LEU LYS TYR GLU CYS TYR ASP LEU LEU SEQRES 18 B 292 SER THR MET ASP ILE SER ASP CYS PHE ILE ASP GLY ASN SEQRES 19 B 292 GLU ASN GLY ASP LEU LEU TRP ASP PHE LEU THR GLU THR SEQRES 20 B 292 CYS ASN PHE ASN ALA THR ALA PRO PRO ASP LEU ARG ALA SEQRES 21 B 292 GLU LEU GLY LYS ASP LEU GLN GLU PRO GLU PHE SER ALA SEQRES 22 B 292 LYS LYS GLU GLY LYS VAL LEU PHE ASN ASN THR LEU SER SEQRES 23 B 292 PHE ILE VAL ILE GLU ALA HET SAH A 400 26 HET HSM A 600 8 HET SAH B 401 26 HET HSM B 601 8 HETNAM SAH S-ADENOSYL-L-HOMOCYSTEINE HETNAM HSM HISTAMINE FORMUL 3 SAH 2(C14 H20 N6 O5 S) FORMUL 4 HSM 2(C5 H9 N3) FORMUL 7 HOH *303(H2 O) HELIX 1 1 HIS A 12 ASN A 24 1 13 HELIX 2 2 THR A 27 LYS A 39 1 13 HELIX 3 3 LYS A 39 ILE A 44 1 6 HELIX 4 4 GLY A 64 TYR A 78 1 15 HELIX 5 5 SER A 91 THR A 105 1 15 HELIX 6 6 THR A 119 LYS A 130 1 12 HELIX 7 7 MET A 144 VAL A 148 5 5 HELIX 8 8 ASP A 150 LEU A 161 1 12 HELIX 9 9 SER A 177 GLY A 187 1 11 HELIX 10 10 SER A 188 PHE A 190 5 3 HELIX 11 11 THR A 200 GLY A 212 1 13 HELIX 12 12 SER A 227 PHE A 230 5 4 HELIX 13 13 ASN A 234 GLU A 246 1 13 HELIX 14 14 ASN A 249 ALA A 254 1 6 HELIX 15 15 PRO A 255 LEU A 266 1 12 HELIX 16 16 ASP B 11 HIS B 25 1 15 HELIX 17 17 THR B 27 LYS B 39 1 13 HELIX 18 18 LYS B 39 GLY B 45 1 7 HELIX 19 19 GLY B 64 TYR B 78 1 15 HELIX 20 20 SER B 91 THR B 105 1 15 HELIX 21 21 THR B 119 LEU B 128 1 10 HELIX 22 22 MET B 144 VAL B 148 5 5 HELIX 23 23 ASP B 150 LEU B 161 1 12 HELIX 24 24 SER B 177 GLY B 187 1 11 HELIX 25 25 SER B 188 PHE B 190 5 3 HELIX 26 26 THR B 200 GLY B 212 1 13 HELIX 27 27 SER B 227 ILE B 231 5 5 HELIX 28 28 ASN B 234 GLU B 246 1 13 HELIX 29 29 ASN B 249 ALA B 254 1 6 HELIX 30 30 PRO B 255 LEU B 266 1 12 SHEET 1 A 7 VAL A 111 HIS A 116 0 SHEET 2 A 7 CYS A 82 VAL A 88 1 N VAL A 87 O HIS A 116 SHEET 3 A 7 GLU A 53 ILE A 59 1 N ILE A 56 O ASN A 84 SHEET 4 A 7 TRP A 136 ILE A 142 1 O PHE A 138 N LEU A 57 SHEET 5 A 7 LEU A 162 VAL A 173 1 O LEU A 169 N ILE A 139 SHEET 6 A 7 LEU A 285 GLU A 291 -1 O ILE A 288 N ILE A 170 SHEET 7 A 7 TYR A 215 LEU A 220 -1 N TYR A 218 O PHE A 287 SHEET 1 B 3 THR A 223 ASP A 225 0 SHEET 2 B 3 LYS A 278 ASN A 282 -1 O PHE A 281 N MET A 224 SHEET 3 B 3 SER A 272 LYS A 275 -1 N ALA A 273 O LEU A 280 SHEET 1 C 2 ARG B 6 SER B 7 0 SHEET 2 C 2 THR B 247 CYS B 248 -1 O CYS B 248 N ARG B 6 SHEET 1 D 7 VAL B 111 HIS B 116 0 SHEET 2 D 7 CYS B 82 VAL B 88 1 N ILE B 83 O LYS B 112 SHEET 3 D 7 GLU B 53 ILE B 59 1 N SER B 58 O VAL B 88 SHEET 4 D 7 TRP B 136 ILE B 142 1 O PHE B 138 N LEU B 57 SHEET 5 D 7 LEU B 162 VAL B 173 1 O GLY B 163 N TRP B 136 SHEET 6 D 7 LEU B 285 GLU B 291 -1 O ILE B 288 N ILE B 170 SHEET 7 D 7 TYR B 215 LEU B 220 -1 N TYR B 218 O PHE B 287 SHEET 1 E 3 THR B 223 ASP B 225 0 SHEET 2 E 3 LYS B 278 ASN B 282 -1 O PHE B 281 N MET B 224 SHEET 3 E 3 SER B 272 LYS B 275 -1 N ALA B 273 O LEU B 280 SITE 1 AC1 18 GLY A 60 GLY A 62 ILE A 66 GLU A 89 SITE 2 AC1 18 PRO A 90 GLN A 94 THR A 119 SER A 120 SITE 3 AC1 18 ILE A 142 GLN A 143 MET A 144 TYR A 147 SITE 4 AC1 18 HOH A 631 HOH A 646 HOH A 773 HOH A 774 SITE 5 AC1 18 HOH A 775 HOH A 776 SITE 1 AC2 16 GLY B 60 GLY B 62 ILE B 66 GLU B 89 SITE 2 AC2 16 PRO B 90 GLN B 94 THR B 119 SER B 120 SITE 3 AC2 16 ILE B 142 GLN B 143 MET B 144 TYR B 147 SITE 4 AC2 16 HOH B 624 HOH B 722 HOH B 723 HOH B 724 SITE 1 AC3 6 PHE A 22 GLU A 28 GLN A 143 VAL A 173 SITE 2 AC3 6 ASN A 283 HOH A 779 SITE 1 AC4 9 PHE B 22 GLU B 28 GLN B 143 TYR B 146 SITE 2 AC4 9 VAL B 173 TRP B 179 PHE B 243 ASN B 283 SITE 3 AC4 9 LEU B 285 CRYST1 131.750 131.750 64.030 90.00 90.00 120.00 P 6 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007590 0.004382 0.000000 0.00000 SCALE2 0.000000 0.008764 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015618 0.00000